About this trial
Infection post liver transplantation is an important factor in the death in patients. The traditional method of diagnosing infection post liver transplantation is laboratory tests. But the sensitivity and specificity of blood tests is poor. Next-generation sequencing (NGS) has greater detection rate for mycobacterium tuberculosis, anaerobes and fungi and greater sensitivity compare with blood tests. However use of NGS is limited because of the short read-length. Oxford nanopore adaptive sequencing (NAS) method is the Third Revolution in Sequencing Technology. For each 1 Gbp of data, NAS sequencing detected 45 times more microbiome sequences than Nanopore standard sequencing and 2.5 times more than Illumina sequencing. The purpose of this study is to compare NAS with NGS and laboratory tests for the diagnostic rate of infection post liver transplantation.
Eligibility criteria
Qualifiers
Accept liver transplantation
Signing informed consent voluntarily
Possessing ability to comprehend material information
Participating this study voluntarily
Disqualifiers
Participated another study
Graft loss
Have undergone a multi-organ transplantion or have had a previous organ transplantation
Patient died
Trial design
Treatments tested in this trial
- NAS, NGS and Laboratory tests